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Volume 51, Number 2 Abstracts 533chronic renal failure, chronic obstructive pulmonary disease, CABG/V, and
CAS (Table II). CAS carried a 2.5-fold increased risk of stroke or death vs
CEA.
Conclusions: CAS from 2004 to 2006 had a higher risk of stroke and
death than CEAwith and without CABG/V, even after adjustment for CMS
high-risk criteria. Further risk-adjusted prospective and randomized analyses
are needed before broad expansion of CAS.
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Introduction: Emerging data support a role for negative wall remod-
eling in the failure of vascular interventions such as vein grafts, yet clinicians
and researchers currently lack the ability to temporally and efficiently inter-
rogate the adventitial surface topography and total vascular wall anatomy in
vivo. Our long-term goal is the development of an implantable contrast
material immobilized on the vein conduit outer surface ex vivo at the time of
operation that will allow high-throughput and spatial resolution vascular
wall imaging in vivo longitudinally. We hypothesized that commercially
available iron (Fe) magnetic nanoparticles can be covalently immobilized
onto the human vein graft wall and subsequently enable delineation of the
adventitia with magnetic resonance imaging (MRI).
Methods: Carboxy-modified Fe nanoparticles (30 nm) were activated
through N-hydroxysuccinimide ester, incubated on human vein adventitia
(covalently binds to amines), and thoroughly rinsed. Vein segments were
imaged on a 3T MRI system with proton-density, T2*, T1, inversion-
recovery contrasts. Histology served as the morphometric standard.
Results: The Fe nanoparticles induced a thin layer of negative contrast
Table I. Demographics and comorbidities
Variables CEA CAS Pa
Total patients, No (%) 367,255 (90.1) 40,404 (9.9)
With CABG/V 10,719 (2.9) 399 (1.0) .001
Without CABG/V 348,414 (97.1) 38,166 (99.0) .001
Age 80 y, % 16.8 17.5 .08
Female, % 42.6 39.8 .001
CHF, % 6.7 10.1 .001
Renal failure, % 4.0 6.8 .001
COPD, % 21.5 18.1 .001
Symptomatic, % 9.6 13.6 .001
With CABG/valve 6.9 13.3 .05
Without CABG/V 9.5 13.5 .001
Stroke or death, % 1.4 3.6 .001
With CABG/V 7.0% 11.4 .13
Without CABG/V 1.3% 3.5 .001
Mortality 0.6% 1.7 .001
With CABG/V 4.0% 6.4 .30
Without CABG/V 0.4% 1.7 .001
CABG/V, Coronary artery bypass grafting with valve surgery; CAS, carotid
artery stenting; CEA, carotid endarterectomy; CHF, congestive heart fail-
ure; COPD, chronic obstructive pulmonary disease.
aP  .05 is statistically significant.
Table II. Multivariate predictors of stroke or death
Predictor OR 95% CI Pa
Carotid artery stenting 2.5 2.2-2.8 .001
Symptomatic 7.1 6.3-8.0 .001
CABG/V (vs no cardiac procedure) 6.8 5.7-8.1 .001
Congestive heart failure 2.2 1.8-2.5 .001
Chronic renal failure 1.6 1.3-2.0 .001
COPD 1.2 1.05-1.4 .01
Age (by decade) 1.1 1.02-1.14 .05
Female gender 1.1 1.0-1.2 .19
CABG/V,Coronary artery bypass grafting with valve surgery;CI confidence
interval; COPD, chronic obstructive pulmonary disease; OR, odds ratio.
aP  .05 is statistically significant.that differentiated the adventitia from surrounding saline signal in all MRIs
(Fig A and B), enabling delineation of wall anatomy (C); this was notpossible in simultaneously imaged unlabeled control veins (D). Fe dose/
response was also observed (B, low [left] to high [right] dose).
Conclusions: Fe can be immobilized (dose-dependent) on human vein
for MRI detection, greatly enhancing subsequent delineation of total wall
anatomy. This novel imaging approach offers a potentially revolutionary
strategy for longitudinal enhancement of vascular biology imaging in vivo.
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Introduction: Vein graft adaptation (VGA) is characterized by thick-
ening of the vein wall, a complex process involving cell proliferation and
migration. We have previously shown that VGA is also characterized by loss
of the venous determinant Eph-B4.We developed an in vitro model to study
molecular mechanisms that mediate VGA.
Methods: Aortic interposition grafts were examined using vein from
wild-type and Eph-B4 heterozygous knockout (Eph-B4-KO) mice. Endo-
thelial cells (EC) were isolated from wild-type and Eph-B4-KO mice. Cell
proliferation was directly counted. Quantitative polymerase chain reaction
(qPCR) was used to evaluate basal messenger RNA (mRNA) expression.
Western blot was used to evaluate protein levels. Under basal and Ephrin-
B2/Fc-stimulated conditions, angiogenic tube formation was measured by
tube formation assay, cell migration was evaluated using a Boyden chamber,
and nitric oxide (NO) production was evaluated fluorometrically.
Results: Vein grafts from Eph-B4-KO mice had 50% increased neoin-
timal thickness vs wild-type vein grafts (P  .01). Under basal conditions,
Eph-B4-KO cells proliferated 41% more slowly than wild-type EC (P 
.029) and 43% more slowly when stimulated with Ephrin-B2/Fc. Basal
levels of Akt were 29% higher, and vascular endothelial growth factor
(VEGF) was 28% lower in Eph-B4-KO cells vs wild-type EC. Under direct
stimulation, levels of phosphorylated Akt were 31% greater and levels of
phosphorylated extracellular signal-regulated kinase 1/2 were 12% greater
in Eph-B4-KO cells vs wild-type cells. QPCR confirmed 49% less VEGF-A
mRNA expression in Eph-B4-KO cells. Eph-B4-KO cells had 87% greater
angiogenic tube formation (P .001) and 14% greater NO production (P
.0092) under stimulated conditions. Eph-B4-KO cells had 60% reduced cell
migration in response to Ephrin-B2/Fc (P  .005).
Conclusions: EC isolated from Eph-B4-KO mice is a novel in vitro
cellular model of VGA. This model suggests that reduced Eph-B4 expres-
sion during VGA may be mediated by upstream signals such as VEGF-A as
well as downstream signal pathways such as Akt.
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Fig. A, Fe nanoparticles induced a layer of negative contrast in
magnetic resonance imaging (MRI) that differentiated the adven-
titia from surrounding saline. B, Fe dose/response from low to
high is shown left to right. MRI showed wall anatomy in (C)
Fe-labeled vein but (D) not in unlabeled control veins (D).Introduction: In patients with peripheral vascular disease, claudication
is a frequent symptom related to skeletal muscle demand ischemia. These
